CME Information
Provider Statement: This continuing medical education activity is provided by 
.
Support Statement: This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Target Audience: The intended audience for this activity is retina specialists and other health care professionals involved in the treatment of patients with retinal vascular diseases.
Learning Objectives: Upon successful completion of this activity, participants should be better able to:
- Evaluate the impact of optimizing therapeutic regimens for retinal diseases on visual outcomes.
- Review new comparative evidence for the effectiveness of current anti-VEGF agents in treating retinal diseases.
- Assess techniques and technology that advance the clinical utility of intravitreal therapy.
- Examine the safety, efficacy, and potential clinical utility of emerging intravitreal treatments for retinal diseases.
- Assess new real-world and clinical trial data about the safety and efficacy of intravitreal corticosteroids in retinal diseases.
Chief Medical Editor:
Rishi P. Singh, MD
Staff Physician, Cole Eye Institute
Medical Director, Clinical Systems Office
Cleveland Clinic
Associate Professor of Ophthalmology
Case Western Reserve University
Cleveland, OH
Faculty:
Sophie J. Bakri, MD
Professor of Ophthalmology
Mayo Clinic
Rochester, MN
Yasha Modi, MD
Assistant Professor of Retinal Disease and Vitreoretinal Surgery
New York University
New York, NY
Darius M. Moshfeghi, MD
Professor
Byers Eye Institute
Stanford University School of Medicine
Palo Alto, CA
Aleksandra V. Rachitskaya, MD
Vitreoretinal Physician, Cole Eye Institute
Cleveland Clinic
Assistant Professor of Ophthalmology, Cleveland Clinic
Lerner College of Medicine
Cleveland, OH
Reviewer:
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, March 29, 2018 through March 28, 2019.
How to Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, review the articles, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 7 out of 10 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears above.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Chief Medical Editor and Faculty members report the following relationship(s):
Rishi P. Singh, MD
Consulting Fee: Alcon, Allergan, Genentech, Optos, Regeneron, Shire, Zeiss
Contracted Research: Alcon, Apellis, Genentech, Regeneron
Sophie J. Bakri, MD
Consulting Fee: Allergan, Genentech, Novartis, Zeiss
Yasha Modi, MD
Consulting Fee: Genentech
Darius M. Moshfeghi, MD
Speaker Honoraria: Regeneron
Aleksandra V. Rachitskaya, MD
Consulting Fee: Allergan, Zeiss
Contracted Research: Genentech, Novartis, Regeneron
Reviewer reports the following relationships:
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2018 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com